aprocitentan   Click here for help

GtoPdb Ligand ID: 10070

Synonyms: ACT-132577 | ACT132577 | Tryvio®
Approved drug
aprocitentan is an approved drug (FDA (2024))
Compound class: Synthetic organic
Comment: Aprocitentan (ACT-132577) is an orally bioavailable endothelin receptor antagonist (ERA) and a pharmacologically active metabolite of macitentan [2,4]. It was designed to treat hypertension, in particular for resistant hypertension [1,6].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 8
Hydrogen bond donors 2
Rotatable bonds 8
Topological polar surface area 150.59
Molecular weight 543.92
XLogP 2.98
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES Brc1ccc(cc1)c1c(OCCOc2ncc(cn2)Br)ncnc1NS(=O)(=O)N
Isomeric SMILES Brc1ccc(cc1)c1c(OCCOc2ncc(cn2)Br)ncnc1NS(=O)(=O)N
InChI InChI=1S/C16H14Br2N6O4S/c17-11-3-1-10(2-4-11)13-14(24-29(19,25)26)22-9-23-15(13)27-5-6-28-16-20-7-12(18)8-21-16/h1-4,7-9H,5-6H2,(H2,19,25,26)(H,22,23,24)
InChI Key DKULOVKANLVDEA-UHFFFAOYSA-N
Selectivity at GPCRs
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
ETA receptor Hs Antagonist Antagonist 6.7 pA2 - 2
pA2 6.7 [2]
ETB receptor Hs Antagonist Antagonist 5.5 pA2 - 2
pA2 5.5 [2]
ETA receptor Hs Antagonist Antagonist 8.5 pIC50 - 2
pIC50 8.5 (IC50 3.4x10-9 M) [2]
ETB receptor Hs Antagonist Antagonist 6.0 pIC50 - 2
pIC50 6.0 (IC50 9.87x10-7 M) [2]